Article info
PDFExtended reports
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy
- Correspondence to:
Dr E Kruithof
Department of Rheumatology, OK12IB, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium; elli.kruithofUGent.be
Citation
Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodelling of the synovial membrane in spondyloarthropathy
Publication history
- Accepted August 12, 2004
- First published September 23, 2004.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Annals of the Rheumatic Diseases